Rossari Biotech Limited

NSEI:ROSSARI Stock Report

Market Cap: ₹42.9b

Rossari Biotech Balance Sheet Health

Financial Health criteria checks 6/6

Rossari Biotech has a total shareholder equity of ₹11.2B and total debt of ₹1.4B, which brings its debt-to-equity ratio to 12.8%. Its total assets and total liabilities are ₹17.1B and ₹5.9B respectively. Rossari Biotech's EBIT is ₹1.9B making its interest coverage ratio 14.5. It has cash and short-term investments of ₹800.1M.

Key information

12.8%

Debt to equity ratio

₹1.43b

Debt

Interest coverage ratio14.5x
Cash₹800.08m
Equity₹11.18b
Total liabilities₹5.93b
Total assets₹17.11b

Recent financial health updates

Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Jun 14
Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Recent updates

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Jun 14
Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

May 07
Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

May 03
Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Sep 23
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Apr 06
Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Feb 19
Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

Feb 17
Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Feb 10
I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

Nov 24
Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Oct 12
With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 17
Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Oct 26
Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Financial Position Analysis

Short Term Liabilities: ROSSARI's short term assets (₹9.4B) exceed its short term liabilities (₹4.5B).

Long Term Liabilities: ROSSARI's short term assets (₹9.4B) exceed its long term liabilities (₹1.4B).

Debt to Equity History and Analysis

Debt Level: ROSSARI's net debt to equity ratio (5.6%) is considered satisfactory.

Reducing Debt: ROSSARI's debt to equity ratio has reduced from 17.4% to 12.8% over the past 5 years.

Debt Coverage: ROSSARI's debt is well covered by operating cash flow (81.3%).

Interest Coverage: ROSSARI's interest payments on its debt are well covered by EBIT (14.5x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y